Ropivacaine 99%

Gland Chemicals (GCL) was established in 1974 by Sri P. V. N. Raju for manufacturing Heparin API. GCL Specializes in injectable API Manufacture and formulations, GCL Manufactures anticoagulants, muscle relaxants, and other range of APIs and formulations. In 2021, GCL acquired Pfizer facilities at Aurangabad and Chennai. Aurangabad facility provides GCL capabilities additional capabilities to manufacture an antibiotic range of APIs as well as additional capacities of other APIs. Chennai facility provides GCL capabilities to produce general sterile injectables as well as an antibiotic range of Injectables. GCL with a long-standing track record of regulatory compliance with various authorities is managed by a team of professionals led by Dr. Ravi Penmetsa who has rich experience in building business of scale in the pharma industry. GCL promoted Gland Pharma in 1978 (A listed company) which is now owned by the Fosun group.